Navigation Links
VAD in Medical News

WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD

OAKLAND, Calif., Jan. 8 /PRNewswire-FirstCall/ -- (Nasdaq: WHRT ) World Heart Corporation ("WorldHeart") announced today that it has submitted an Investigational Device Exemption ("IDE") application to the US Food and Drug Administration ("FDA" or the "Agency") for a pivotal Bridge-to-Transpla...

Thoratec Corporation and HeartWare International, Inc. Announce Termination of Proposed Transaction

...on Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS, with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its In...

Thoratec Schedules Second Quarter Conference Call, Webcast

... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from...

AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure

...Commission’s newly required Disease Specific vad Certification. In the first four months of 2009 a...ne, the hospital’s medical team performed 18 vad implants and is actively involved in several state-of-the-art vad clinical trials for both destination (or permanent...

Thoratec Announces Appointment of Paul LaViolette to Board of Directors

... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from...

Thoratec Presentation at JMP Securities Conference to be Webcast

...oratec.com . Thoratec is world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 13,000 devices implanted in patients suffering from ...

Thoratec Schedules First Quarter Conference Call, Webcast

... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from...

Hahnemann University Hospital Awarded Certification From the Joint Commission for Ventricular Assist Devices

...ients either await a heart transplant, or for destination therapy when transplant is not a viable option. "Hahnemann sought accreditation for our vad program because we wanted to demonstrate our commitment to our patients' safety and quality care," said George Amrom, M.D ., chief medical officer of...

Artificial pump effectively backs up failing hearts

... the trial included stroke and bleeding, and the number and type of adverse events was similar to other LVADs but better than that of first-generation vad devices. Answering standardized questionnaires for patients with heart failure, they reported a significantly improved quality of life after receiv...

Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission

...atec Corporation Thoratec is a leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 12,000 devices implanted in patients suffering from ...

Thoratec Presentation at Raymond James Conference to Be Webcast

...tec.com . Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 12,000 devices implanted in patients suffering from ...

Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;

... 4706062. Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS with more than 12,000 devices implanted in patients suffering from heart failure. Additionally, its Int...

Thoratec Reports 34 Percent Increase in 2008 Revenues

...ing growing penetration with the HeartMate II and the continued addition of vad therapy at a number of open-heart centers. Most importantly, we will be dri...ed-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate LVAS (Left Ventricular Assist Sys...

Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast

... Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from hea...

Thoratec Presentation at Piper Jaffary Conference to be Webcast

...tec.com . Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from hea...

Thoratec Reports 44 Percent Increase in Second Quarter Revenues;

...cial measures. Thoratec is a world leader in therapies to address advanced stage heart failure. The company's product lines include the Thoratec(R) vad and HeartMate LVAS with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporati...

Thoratec Schedules Second Quarter 2008 Conference Call, Webcast

...78. Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate (R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from he...

Thoratec Schedules First Quarter 2008 Conference Call, Webcast

...00. Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) vad (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from ...

Children's Hospital of Pittsburgh of UPMC Involved in Projects To Develop Nation's First Heart Assist Devices for Young Children

...to develop the first totally implantable pediatric vad in the United States that could be used for longer.... In the development of an implantable pediatric vad known as PediaFlow, Children's team is partnering ...ing donor hearts. Until such time as a pediatric vad is developed and approved for use, Children's is o...

National study will look at German-made heart pump for children needing heart transplants

...atric heart pump. At the studys conclusion, Berlin Heart, Inc. will present those data to the FDA for consideration of approval of the EXCOR Pediatric vad for use in the U.S. The Berlin Heart holds a lot of promise for infants and children whose hearts are failing, said Fraser. Its extremely gratifying ...

VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial

... rate of 21 percent compared to 8 percent with vad (p -- Of the 404 patients who proceeded to SCT, t...rate of 41 percent compared to 29 percent with vad (p=0.0089) "Results from this trial build on the ...uring cycles one and two only. The patients in the vad arm were treated for four 28-day cycles with vincr...

Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation

...rld leader in hemodynamic restoration therapy-developing products to treat cardiovascular disease. The company's product line includes the Thoratec(R) vad (Ventricular Assist Device) and HeartMate II LVAS with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its ...

Pumps Someday May Allow Patients to Recover Their Own Hearts

...of cardiac transplantation and mechanical support. Why is he so confident? Because he and other physicians have seen the kind of heart healing a vad can provide. Functioning essentially as surrogate pumps for the heart, the devices have been used for years to help patients who are poor candidates f...

Review Urges Restricted Use Of Devices To Keep Heart Patients Alive

...erse events, but it's certainly better than before vad implantation." The small number of heart-pump...viewers compared health outcomes and costs for the vad patients with patients on the UK's heart transplan...st. The review estimates the average cost of a vad implant operation is 63,830 British pounds (roughl...

Drug Effective for Vascular Dementia

...l of the condition.// Vascular dementia -- or vad -- is usually associated with cardiovascular disea...ple of their cognitive abilities slowly over time, vad often strikes quickly, such as after a stroke. How...rve fiber) deficit, leading researchers to believe vad patients may also benefit from treatment with chol...
Other Tags
(Date:4/16/2014)... Boulder, Colorado, USA - Geoscientists from the north-central U.S. ... 24-25 April to discuss new science, expand on existing ... of the region, with a special emphasis on applied ... talk at 7 p.m. on Thursday by Dr. Kirk ... Natural History. , The meeting is hosted by ...
(Date:4/16/2014)... or to conquer the world? Surprisingly, bacteria also ... in Munich have now shown how these organisms ... , The bacterium Bacillus subtilis is ... on agar surfaces by means of flagella. Alternatively, ... the bacteria proliferate most effectively in this stationary ...
(Date:4/15/2014)... UC Irvine neurobiologists have found that genetically modified neural ... brains of mice with the symptoms and pathology of ... journal Stem Cells Research and Therapy , and ... different mouse models. , Alzheimer,s disease, one of ... accumulation of the protein amyloid-beta in the brain in ...
Breaking Biology News(10 mins):Walking with mammoths and exploring mid-continental geology 2Walking with mammoths and exploring mid-continental geology 3Walking with mammoths and exploring mid-continental geology 4Theoretical biophysics: Adventurous bacteria 2UCI study finds modified stem cells offer potential pathway to treat Alzheimer's disease 2
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
Other Contents